Heidi Cuthbert

Pfizer (NYSE:PFE) disclosed preliminary data from its Phase 2 clinical trial evaluating PF-07872412, an investigational 25-valent pneumococcal conjugate vaccine candidate designed for pediatric use.

SOL’s tokenised real-world asset market expanded 43% quarter over quarter to $2.01 billion in the first quarter of 2026 despite broader weakness across crypto markets.

OncoSil Medical (ASX:OSL) shares surge as the TGA approves its Class III pancreatic cancer device for commercialisation in Australia.

Woodside Energy (ASX:WDS) will consider matching an offer from Inpex to buy PetroChina's 10.67% stake in the Browse gas fields.

Pump.fun remained Solana’s largest revenue-generating application in the first quarter of 2026 after producing $124.7 million, more than one-third of the network’s $342.2 million in total app revenue.

RAS Technology (ASX:RTH) secured a wave of new customer agreements and contract extensions projected to deliver a minimum $2 million boost in annualised revenue.

Bitwise Asset Management said Hyperliquid’s HYPE token remains significantly undervalued because investors still view the platform as a crypto derivatives exchange instead of a broader financial trading “super-app.”

Bank of America disclosed almost $53 million in cryptocurrency exchange-traded fund holdings in its latest quarterly filing with the US Securities and Exchange Commission.

Plenti Group (ASX:PLT) more than doubled its cash profit before tax to a record $30.8 million, representing a 117% surge.

Ripple ranked No. 16 on CNBC’s 2026 Disruptor 50 list as the media network highlighted companies reshaping finance, artificial intelligence, cybersecurity and enterprise software markets.